Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000079

SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $109.27 ($546,353)

  • SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Option exercise 10b5-1 +5,000 $21.41 $107,050 33,623 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Sale 10b5-1 −476 $107.51 $51,175 33,147 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Sale 10b5-1 −996 $108.69 $108,252 32,151 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Sale 10b5-1 −3,147 $109.55 $344,744 29,004 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Sale 10b5-1 −314 $110.51 $34,699 28,690 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Sale 10b5-1 −67 $111.68 $7,483 28,623 D
Derivatives
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-07 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 169,497 D
Open-market sales · 5,000 sh · avg $109.27 · $546,353
Loading xslF345X05/wk-form4_1728433783.xml…